Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Neuronatin regulates pancreatic β cell insulin content and secretion
Steven J. Millership, Gabriela Da Silva Xavier, Agharul I. Choudhury, Sergio Bertazzo, Pauline Chabosseau, Silvia M.A. Pedroni, Elaine E. Irvine, Alex Montoya, Peter Faull, William R. Taylor, Julie Kerr-Conte, Francois Pattou, Jorge Ferrer, Mark Christian, Rosalind M. John, Mathieu Latreille, Ming Liu, Guy A. Rutter, James Scott, Dominic J. Withers
Steven J. Millership, Gabriela Da Silva Xavier, Agharul I. Choudhury, Sergio Bertazzo, Pauline Chabosseau, Silvia M.A. Pedroni, Elaine E. Irvine, Alex Montoya, Peter Faull, William R. Taylor, Julie Kerr-Conte, Francois Pattou, Jorge Ferrer, Mark Christian, Rosalind M. John, Mathieu Latreille, Ming Liu, Guy A. Rutter, James Scott, Dominic J. Withers
View: Text | PDF
Research Article Cell biology Genetics

Neuronatin regulates pancreatic β cell insulin content and secretion

  • Text
  • PDF
Abstract

Neuronatin (Nnat) is an imprinted gene implicated in human obesity and widely expressed in neuroendocrine and metabolic tissues in a hormone- and nutrient-sensitive manner. However, its molecular and cellular functions and precise role in organismal physiology remain only partly defined. Here we demonstrate that mice lacking Nnat globally or specifically in β cells display impaired glucose-stimulated insulin secretion leading to defective glucose handling under conditions of nutrient excess. In contrast, we report no evidence for any feeding or body weight phenotypes in global Nnat-null mice. At the molecular level neuronatin augments insulin signal peptide cleavage by binding to the signal peptidase complex and facilitates translocation of the nascent preprohormone. Loss of neuronatin expression in β cells therefore reduces insulin content and blunts glucose-stimulated insulin secretion. Nnat expression, in turn, is glucose-regulated. This mechanism therefore represents a novel site of nutrient-sensitive control of β cell function and whole-animal glucose homeostasis. These data also suggest a potential wider role for Nnat in the regulation of metabolism through the modulation of peptide processing events.

Authors

Steven J. Millership, Gabriela Da Silva Xavier, Agharul I. Choudhury, Sergio Bertazzo, Pauline Chabosseau, Silvia M.A. Pedroni, Elaine E. Irvine, Alex Montoya, Peter Faull, William R. Taylor, Julie Kerr-Conte, Francois Pattou, Jorge Ferrer, Mark Christian, Rosalind M. John, Mathieu Latreille, Ming Liu, Guy A. Rutter, James Scott, Dominic J. Withers

×

Figure 5

ER membrane topology of NNAT and its direct effect on SPC processing.

Options: View larger image (or click on image) Download as PowerPoint
ER membrane topology of NNAT and its direct effect on SPC processing.
(A...
(A) Representative Western blotting analysis of in vitro–translated preproinsulin converted to proinsulin in the presence (+) of pancreatic microsomes with and without coexpression of NNAT, expressed as percentage processing of preproinsulin. Coexpression of GFP was used as a control (n = 5 reactions per group, *P < 0.05, Mann-Whitney U test). (B) INS1E cells with Nnat siRNA knockdown versus scramble siRNA control were permeabilized with digitonin or Triton X-100, immunostained using an antibody that detects all insulin species (Insulins, green) and also NNAT (red), and visualized by confocal microscopy. The luminal ER protein PDI (green) was used to assess membrane permeabilization, and nuclei were visualized with DAPI. Scale bar: 10 μm. Fields of view were quantified for total fluorescence using ImageJ (NIH) from insulin-stained cells permeabilized with digitonin and normalized to cell number (Student’s t test, ***P < 0.001). (C) Representative Western blotting analysis of C-terminal c-Myc–tagged SPCS3 and SEC11A, and FLAG-tagged NNAT translated in vitro in the presence (+) or absence (–) of pancreatic microsomes and treated with proteinase K (Prot. K) (n = 3 reactions per group, mean vs. absence of microsomes, **P < 0.01, Student’s t test vs. presence of microsomes). (D) Immunofluorescent staining of INS1E cells permeabilized with digitonin or Triton X-100 with use of antibodies against NNAT (red) and PDI (green) visualized by confocal microscopy. PDI was used to assess membrane permeabilization, and nuclei were visualized with DAPI. Scale bar: 10 μm. (E) Topology of NNAT (green) and subunits of the SPC (black) on the ER membrane. The catalytic site for signal peptidase cleavage in SEC11A/C is shown in blue (N and C, amino- and carboxy terminal, respectively).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts